VivoPower International has announced the commencement of its Stock Buyback Program, authorized by its Board of Directors, with a total budget of up to $5 million for purchasing outstanding shares.

The Company has entered into a Controlled Equity Offering Sales Agreement SM with the sales agents named therein (the “Sales Agreement”) pursuant to which it may offer and sell, under the Prospectus ...

BioRestorative Therapies, Inc. has announced a stock repurchase program authorized by its Board of Directors, allowing the company to buy back up to $2 million of its common stock until June 16, 2026.

Companies have been feverishly announcing plans to buy back their own stock this year, despite the S&P 500’s 20% surge to record highs and the 1% tax in place on share repurchases. Announced buyback ...

On August 12, 2025, the Board approved a reverse stock split of the Company’s outstanding shares of Common Stock at a ratio of one-for-five (the “Reverse Stock Split”). The Reverse Stock Split is ...